La Pampa expondrá a la comunidad científica los resultados del Programa de Intervención Monitoreado de Ivermectina

Ivermectin study #109 of 113 Meta Analysis

8/10 News

La Pampa, Argentina (News)
La Pampa expondrá a la comunidad científica los resultados del Programa de Intervención Monitoreado de Ivermectina

Source PDF Share Tweet

News report on the use of ivermectin in La Pampa, Argentina, showing lower mortality with treatment.

La Pampa et al., 8/10/2021, retrospective, Argentina, South America, preprint, 1 author, dosage 600μg/kg days 1-5.

risk of death, 27.4% lower, RR 0.73, treatment 3269, control 18149.

risk of combined death/ICU, 38.0% lower, RR 0.62, treatment 3269, control 18149.

risk of death, 33.4% lower, RR 0.67, treatment 3269, control 18149, >40yo.

risk of death, 44.0% lower, RR 0.56, treatment 3269, control 18149, >40yo including comorbidities.

This study is excluded in meta analysis: detail too minimal.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.

All 113 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit